- Home
- CBFV vs SAVA Comparison
CBFV vs SAVA Comparison
Compare CBFV & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CBFV
- SAVA
- Stock Information
- Founded
- CBFV 1901
- SAVA 1998
- Country
- CBFV United States
- SAVA United States
- Employees
- CBFV N/A
- SAVA N/A
- Industry
- CBFV Major Banks
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- CBFV Finance
- SAVA Health Care
- Exchange
- CBFV Nasdaq
- SAVA Nasdaq
- Market Cap
- CBFV 153.2M
- SAVA 157.5M
- IPO Year
- CBFV N/A
- SAVA N/A
- Fundamental
- Price
- CBFV $33.25
- SAVA $2.94
- Analyst Decision
- CBFV Buy
- SAVA Buy
- Analyst Count
- CBFV 2
- SAVA 2
- Target Price
- CBFV $36.00
- SAVA $5.00
- AVG Volume (30 Days)
- CBFV 6.4K
- SAVA 1.9M
- Earning Date
- CBFV 10-23-2025
- SAVA 11-07-2025
- Dividend Yield
- CBFV 3.14%
- SAVA N/A
- EPS Growth
- CBFV N/A
- SAVA N/A
- EPS
- CBFV 0.51
- SAVA N/A
- Revenue
- CBFV $40,244,000.00
- SAVA N/A
- Revenue This Year
- CBFV $10.71
- SAVA N/A
- Revenue Next Year
- CBFV $12.52
- SAVA N/A
- P/E Ratio
- CBFV $65.13
- SAVA N/A
- Revenue Growth
- CBFV N/A
- SAVA N/A
- 52 Week Low
- CBFV $26.01
- SAVA $1.15
- 52 Week High
- CBFV $34.00
- SAVA $33.98
- Technical
- Relative Strength Index (RSI)
- CBFV 56.58
- SAVA 38.68
- Support Level
- CBFV $31.81
- SAVA $3.62
- Resistance Level
- CBFV $33.99
- SAVA $3.06
- Average True Range (ATR)
- CBFV 0.60
- SAVA 0.25
- MACD
- CBFV -0.00
- SAVA -0.15
- Stochastic Oscillator
- CBFV 73.18
- SAVA 9.51
About CBFV CB Financial Services Inc.
CB Financial Services Inc operates as a bank holding company. The company conducts its operations through its wholly-owned subsidiary, Community Bank, a Pennsylvania-chartered commercial bank. The Bank offers products and services related to residential and commercial real estate loans, commercial and industrial loans, and consumer loans, as well as a range of deposit products for individuals and businesses in its market area. It operates in two operating units namely Community Banking and Insurance brokerage service segment. The bank generates its revenue in the form of interest.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia. It has one business segment: the development of novel drugs and diagnostics.